{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/12/3310977/0/en/Kymera-Therapeutics-Presents-Phase-1-Data-in-Healthy-Japanese-Adults-for-KT-621-a-First-in-Class-Oral-STAT6-Degrader-at-the-Japanese-Dermatological-Association-Annual-Meeting.html", "message": "News view counter 795705 successfully enlarged"}